"Artificial Pancreas Boosts Glycemic Control In Type 1 Diabetes" - Marilynn Larkin
Use of an artificial pancreas system significantly improves glycemic control while reducing hypoglycemia in patients with type 1 diabetes, according to a systematic review of randomized controlled trials. Carol Levy, MD, director of the Mount Sinai Diabetes Center and T1 Diabetes Clinical Research at the Icahn School of Medicine at Mount Sinai said, "The concept of artificial pancreas systems is very exciting for people with diabetes because it reduces the burden of self care by providing help in terms of maintaining glucose control." She added that “the system available in the U.S. is a hybrid, so the patient still has to do something to help clean up the highs and lows. However, I’m confident that they’ll be able to make revisions. To continue to improve, we need many more iterations of development.”
- Carol Levy, MD, CDE, Associate Professor, Endocrinology, Diabetes and Bone Disease, Obstetrics, Gynecology and Reproductive Science, Director, Mount Sinai Diabetes Center, T1 Diabetes Clinical Research, Icahn School of Medicine at Mount Sinai